Who
Lantheus Alpha Therapy, LLC
10% owner
Company insider
Files Form 4 as: 10% owner, Perspective Therapeutics.
In numbers
- Trades disclosed
- 10
- Buys
- 1
- Sells
- 5
- Bought
- $57.4M
- Sold
- $2.4M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 6 Mar 2024
- Last trade
- 4 Sep 2026
- Last filed
- 8 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 8 Sep 2026 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Sold | $526K167,149 at $3.15 | filing |
| 4 Sep 2026filed 8 Sep 2026 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Sold | $527K167,149 at $3.15 | filing |
| 3 Sep 2026filed 8 Sep 2026 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Sold | $251K80,783 at $3.11 | filing |
| 3 Sep 2026filed 8 Sep 2026 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Sold | $251K80,783 at $3.11 | filing |
| 2 Sep 2026filed 4 Sep 2026 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Sold | $131K42,129 at $3.11 | filing |
| 1 Sep 2026filed 4 Sep 2026 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Sold | $112K35,769 at $3.12 | filing |
| 1 Sep 2026filed 4 Sep 2026 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Sold | $112K35,769 at $3.12 | filing |
| 31 Aug 2026filed 4 Sep 2026 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Sold | $246K78,145 at $3.14 | filing |
| 31 Aug 2026filed 4 Sep 2026 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Sold | $245K78,145 at $3.14 | filing |
| 6 Mar 2024filed 8 Mar 2024 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $57.4M60,431,039 at $0.95 | filing |
News
No headline names them, or the companies they trade most, lately.